SCHEMBL23421687

SCHEMBL23421687

Cc1cc2c(cc1Nc1ccc3c(c1)oc1ccccc13)C(C)(C)CCC2(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 8/20 0.41
▸ RAB9A P51151 8/20 0.41
▸ NPC1 O15118 7/20 0.41
▸ MEN1 O00255 7/20 0.41
▸ KMT2A Q03164 7/20 0.41
▸ GAA P10253 3/20 0.41
▸ LMNA P02545 5/20 0.41
▸ HTT P42858 3/20 0.41
▸ HPGD P15428 5/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ MAPT P10636 4/20 0.40
▸ TP53 P04637 4/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ ALDH1A1 P00352 7/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ DUSP3 P51452 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24562625 0.93 ALDH1A1 (0.38) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL23438794 0.90 ALDH1A1 (0.36) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL23422190 0.85 CYP26A1 (0.38) LMNAALDH1A1L3MBTL1
SCHEMBL23439428 0.85 RXRA (0.34) MEN1KMT2ALMNATP53ALDH1A1
SCHEMBL30388350 0.85 KMT2A (0.45) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL23421632 0.85 KMT2A (0.45) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL23439362 0.83 ALDH1A1 (0.40) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL23439698 0.82 MEN1 (0.33) SMN1; SMN2MEN1KMT2ALMNAALDH1A1
SCHEMBL23439921 0.82 DUSP3 (0.41) SMN1; SMN2RAB9ANPC1MEN1KMT2A
SCHEMBL23439372 0.81 ALDH1A1 (0.41) SMN1; SMN2RAB9AGAALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230106317-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2023-04-06 — — US disclosed
WO-2021107711-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-06-03 — — WO disclosed
WO-2021107711-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-06-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230106317-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CCNL2, NR1H3, NR1H2 SMN1; SMN2 3624/4885RAB9A 3203/4885NPC1 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback